综合版征稿启事

Group 1 - The article focuses on the new dynamics, initiatives, and achievements of drug regulatory departments in China, aiming to create a platform for experience exchange and showcase results across the national drug supervision landscape [1] - It emphasizes the importance of regulatory measures in promoting the development of the pharmaceutical industry, encouraging submissions that detail successful practices and outcomes [5] - The article outlines the need for clear and structured submissions, with a word count requirement of 2000-2500 words for detailed descriptions of regulatory practices [3][7] Group 2 - The article calls for contributions that highlight the enforcement of quality and safety responsibilities by drug regulatory departments, detailing specific practices and their effectiveness [5] - It encourages the selection of distinctive practices and the inclusion of concrete examples to illustrate implementation and results [6] - The submission guidelines also specify a word count of 2000-2500 words for these contributions [7] Group 3 - The article invites exploratory articles addressing challenges and hot topics in drug regulation, focusing on specific areas to analyze current situations, identify issues, and propose suggestions for enhancing regulatory effectiveness [9] - It requires submissions to be clear and in-depth, with a word count of 1500-2500 words [10] Group 4 - The article includes a section for photo news that showcases the dynamics of drug regulatory work, including safety supervision, industry support, and public awareness activities [11] - It specifies that photos should be at least 1MB in size and must feature clear themes and clean visuals [12] Group 5 - The call for submissions is ongoing, with specific instructions regarding the use of AI tools in the writing process and the requirement to indicate the submission category in the email title [13]